Skip to content

Treatment education

Know what to ask before considering treatment.

These pages are educational. They do not replace a diagnosis, medical advice, a clinician’s review, or the official prescribing information for any medication.

Educational overviews

Two commonly discussed treatment categories

Semaglutide

A GLP-1 receptor agonist used in certain FDA-approved products for specific indications. Form, access, and appropriateness vary.

Read the semaglutide overview →

Tirzepatide

A dual GIP and GLP-1 receptor agonist used in certain FDA-approved products for specific indications. It is not a GLP-2 medication.

Read the tirzepatide overview →

Important

Treatment is never automatic.

A completed assessment does not guarantee eligibility, a prescription, a specific medication, or any particular result.

Review safety information